IRIS
FASANO, Serena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.510
NA - Nord America 1.374
AS - Asia 1.092
SA - Sud America 198
Continente sconosciuto - Info sul continente non disponibili 74
AF - Africa 9
OC - Oceania 1
Totale 5.258
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.729
US - Stati Uniti d'America 1.345
IE - Irlanda 313
SG - Singapore 297
HK - Hong Kong 271
CN - Cina 228
IT - Italia 190
BR - Brasile 153
VN - Vietnam 120
GB - Regno Unito 83
KR - Corea 61
DE - Germania 36
FR - Francia 36
IN - India 35
GR - Grecia 27
SE - Svezia 26
UA - Ucraina 22
AR - Argentina 18
JP - Giappone 16
BD - Bangladesh 13
TR - Turchia 12
ES - Italia 10
PL - Polonia 10
CA - Canada 9
MX - Messico 9
EC - Ecuador 8
FI - Finlandia 7
CO - Colombia 6
ID - Indonesia 5
IQ - Iraq 5
NL - Olanda 5
VE - Venezuela 5
MY - Malesia 4
PK - Pakistan 4
PT - Portogallo 4
AT - Austria 3
CR - Costa Rica 3
JM - Giamaica 3
PA - Panama 3
PY - Paraguay 3
AZ - Azerbaigian 2
BE - Belgio 2
CL - Cile 2
CZ - Repubblica Ceca 2
EE - Estonia 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
SA - Arabia Saudita 2
TN - Tunisia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EU - Europa 1
GL - Groenlandia 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
MA - Marocco 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.186
Salva come PNG Salva come JPEG
Città #
Moscow 597
Dublin 313
Hong Kong 264
Santa Clara 200
San Jose 193
Ashburn 120
Singapore 108
Chandler 96
Council Bluffs 94
Jacksonville 69
Seoul 59
Ho Chi Minh City 43
Beijing 41
Hefei 36
Princeton 33
Hanoi 32
Roxbury 32
Milan 27
Medford 24
Bremen 20
Caserta 15
Los Angeles 14
Bengaluru 13
New York 13
The Dalles 13
Cambridge 11
Des Moines 11
Naples 11
Dallas 10
São Paulo 10
Da Nang 9
Miano 9
Haiphong 8
Jinan 8
Nanjing 8
North Bergen 8
Pamplona 8
Tokyo 8
Warsaw 8
Wilmington 8
Boardman 7
Ann Arbor 6
Chennai 6
Chicago 6
Guangzhou 6
Rio de Janeiro 6
Dhaka 5
Marseille 5
San Francisco 5
Atlanta 4
Brooklyn 4
Buenos Aires 4
Caracas 4
Guayaquil 4
Mexico City 4
Napoli 4
Phoenix 4
Sant'Angelo in Formis 4
Shanghai 4
Villa Literno 4
Belo Horizonte 3
Biên Hòa 3
Boston 3
Campinas 3
Campo Grande 3
Changsha 3
Columbus 3
Falkenstein 3
Francavilla Fontana 3
Frankfurt am Main 3
Goiânia 3
Hyderabad 3
Marília 3
Mumbai 3
Quảng Ngãi 3
Rome 3
Shenyang 3
Taviano 3
Almaty 2
Aparecida de Goiânia 2
Baku 2
Betim 2
Bishkek 2
Brussels 2
Bắc Ninh 2
Calgary 2
Charleston 2
Denver 2
Essex 2
Guarulhos 2
Gwangju 2
Hebei 2
Hillsboro 2
Huế 2
Hải Dương 2
Jiaxing 2
Johannesburg 2
Juiz de Fora 2
Kingston 2
Kraków 2
Totale 2.798
Salva come PNG Salva come JPEG
Nome #
Biologic treatments for idiopathic inflammatory myopathies 199
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus 156
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study 153
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 151
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: A long-term retrospective cohort study 151
Low-dose aspirin as primary prophylaxis for cardiovascular events in rheumatoid arthritis: an Italian multicentre retrospective study 136
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 135
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 133
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease. 132
Precision medicine in systemic lupus erythematosus 131
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 131
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 130
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 126
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 126
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 122
ILC3 in Axial Spondyloarthritis: the Gut Angle 121
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 120
Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries 119
"What is fuelling the immune response in systemic lupus erythematosus?" Evaluating the key metabolites driving plasmablast differentiation 117
Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review 116
Current pharmacological treatment of idiopathic inflammatory myopathies 116
Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE? 114
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 114
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus 113
Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation 112
Mortality in Italian patients with rheumatoid arthritis: Evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center 112
Rituximab in the treatment of inflammatory myopathies: a review 108
Lung involvement in stable undifferentiated connective tissue diseases: a rheumatology perspective 106
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 106
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus 104
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 102
Subclinical Pancreatitis as Onset of Systemic Lupus Erythematosus: Case Report and Review of the Literature 98
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 96
Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolve 95
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study 92
Present and novel biologic drugs in primary Sjogren's syndrome 91
Thrombocytopenia in the Antiphospholipid Syndrome 90
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual 88
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 88
Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis 88
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 84
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: Results of the DeSScipher inception cohort study 84
Systemic lupus erythematosus and the role of the GP 81
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview 81
The role of aspirin in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases 80
Recognition and management of systemic lupus erythematosus 67
Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study 22
Potential involvement of IL-40 in kidney disease associated to systemic lupus erythematosus 21
Totale 5.258
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022188 0 0 0 3 82 0 9 4 10 3 12 65
2022/2023485 39 3 20 14 50 29 0 23 281 1 13 12
2023/2024191 16 17 13 15 80 6 0 1 1 1 5 36
2024/2025749 1 20 4 13 99 94 91 106 63 167 65 26
2025/20262.815 91 126 146 124 257 1.594 142 61 106 64 49 55
2026/2027485 16 56 237 176 0 0 0 0 0 0 0 0
Totale 5.258